WTA introduces gene testing for all players on women’s tennis tour
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
BERLIN (AP) — The Women’s Tennis Association is introducing one-off mandatory gene-testing for all players effective from Tuesday – a requirement to compete at the 2028 Los Angeles Olympics.
The WTA updated its women’s eligibility policy to include gender screening “based on biological sex” this week “to preserve the integrity of women’s professional tennis and maintain fair competition conditions for all players.”
The new policy takes the organization in line with the eligibility policy introduced by the International Olympic Committee in March to align with U.S. President Donald Trump’s executive order on sports ahead of the 2028 Games.
The WTA is complying with what is effectively an order from the IOC that Olympic sports bodies are following, though it remained unclear how many, if any, transgender women are competing at Games level.
Players are to be tested for the SRY gene, a segment of DNA typically found on the Y chromosome that initiates male sex development in utero and indicates the presence of testes.
“In this policy, ‘biological male’ means an individual who, regardless of their legal sex or gender identity, has an SRY gene and therefore has or previously had testes or streak testes; and ‘biological female’ means an individual who, regardless of their legal sex or gender identity, has no SRY gene and therefore has or previously had ovaries or streak ovaries.”
The WTA said the policy distinguishes between biological sex and gender identity, and that there is “no intent to disrespect or question the gender identity or the dignity of any person.”
The mandatory gender screening — already conducted by the governing bodies of track and field, skiing and boxing — has been criticized by human rights experts and activist groups.
___
AP tennis: https://apnews.com/hub/tennis